Effect of green tea polyphenols on angiogenesis induced by an angiogenin-like protein

Biochemical and Biophysical Research Communications

Volumn 308, Issue 1, 2003, Pages 64-67

  Maiti, Tushar Kanti ^a   Chatterjee, Juin ^a   Dasgupta, Swagata ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Angiogenesis; Angiogenin like protein; Catechins; Chorioallantoic membrane assay; Tea polyphenols

Indexed keywords

ANGIOGENIN; ANTINEOPLASTIC AGENT; CATECHIN; GREEN TEA EXTRACT; POLYPHENOL DERIVATIVE;

ANGIOGENESIS; ARTICLE; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; GOAT; NONHUMAN; PRIORITY JOURNAL; SERUM; VASCULARIZATION;

CAPRA HIRCUS; GALLUS GALLUS;

EID: 0042850303     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01338-X     Document Type: Article

References (25)

1. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447.
2. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 267:1992;10931-10934.
3. Fett J.W., Strydom D.J., Lobb R.R., Alderman E.M., Bethune J.L., Riordan J.F., Vallee B.L. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry. 20:1985;5480-5486.
4. Shapiro R., Strydom D.J., Olson K.A., Vallee B.L. Isolation of angiogenin from normal human plasma. Biochemistry. 26:1987;5141-5146.
5. Bond M.D., Vallee B.L. Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay. Biochemistry. 27:1988;6282-6287.
6. Maes P., Damart D., Rommens C., Montreuil J., Spik G., Tartar A. The complete amino acid sequence of bovine milk angiogenin. FEBS Lett. 241:1988;41-45.
7. Bond M.D., Strydom D.J., Vallee B.L. Characterization and sequencing of rabbit, pig and mouse angiogenins discernment of functionally important residues and regions. Biochim. Biophys. Acta. 1162:1993;177-186.
8. Maiti T.K., Dasgupta S. Isolation and characterization of an angiogenin-like protein from goat plasma. Protein Peptide Lett. 9:2002;283-288.
9. Hu G.F. Neomycin inhibits angiogenin-induced angiogenesis. Proc. Natl. Acad. Sci. USA. 95:1998;9791-9795.
10. Balentine D.A. Manufacturing and chemistry of tea. Ho C.-T., Huang M.-T., Lee C.Y. Phenolic Compounds in Food and their Effects on Health, Analysis, Occurrence, and Chemistry. vol. 8:1992;102-117 American Chemical Society, Washington, DC.
11. Tosetti F., Ferrari N., De Flora S., Albini A. 'Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J. 16:2002;2-14.
12. Lambert J.D., Yang C.S. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat. Res. 523:2003;201-208.
13. Fujiki H., Suganuma M., Imai K., Nakachi K. Green tea, cancer preventive beverage and/or drug, mini-review. Cancer Lett. 188:2002;9-13.
14. Cutter H., Wu L.-Y., Kim C., Morre D.J., Morre D.M. Is the cancer protective effect correlated with growth inhibitions by green tea (-)-epigallocatechin gallate mediated through an antioxidant mechanism? Cancer Lett. 162:2001;149-154.
15. Ahmad N., Feyes D.K., Nieminen A.L., Agarwal R., Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 89:1997;1881-1886.
16. Yang G.-Y., Liao J., Kim K., Yurkow E.J., Yang C.S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 19:1998;611-616.
17. Kondo T., Ohta T., Igura K., Hara Y., Kaji K. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett. 180:2002;139-144.
18. Chen Z.P., Schell J.B., Ho C.-T., Chen K.Y. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett. 129:1998;173-179.
19. Cao Y., Cao R. Angiogenesis inhibited by drinking tea. Nature. 398:1999;381.
20. Shapiro R., Vallee B.L. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc. Natl. Acad. Sci. USA. 84:1987;2238-2241.
21. Bond M.D. An in vitro binding assay for angiogenin using placental ribonuclease inhibitor. Anal. Biochem. 173:1988;166-173.
22. Knighton D., Asuprunk D., Tapper D., Folkman J. Br. J. Cancer. 35:1977;347-356.
23. Hu G.F., Chang S.I., Riordan J.F., Vallee B.L. An angiogenin-binding protein from endothelial cells. Proc. Natl. Acad. Sci. USA. 88:1991;2227-2231.
24. Badet J., Soncin F., Guitton J.D., Lamare O., Cartwright T., Barritault D. Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc. Natl. Acad. Sci. USA. 86:1989;8427-8431.
25. Shapiro R., Vallee B.L. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc. Natl. Acad. Sci. USA. 84:1987;2238-2241.